Pharmacists describe their experiences using DEA certificates for controlled substance prescribing in different practice settings, as well as barriers and opportunities for future expansion.
|Articles|October 1, 2006
- Volume 0 0
USE OF ASPIRIN AND IBUPROFEN
Author(s)Anna D. Garrett, PharmD, BCPS, CPP
Advertisement
A recent warning issued by the FDA cautions health care providers regarding a potential interaction between lowdose aspirin and ibuprofen. Ex vivo studies have shown that ibuprofen interferes with the antiplatelet effects of aspirin (81 mg immediate-release). This interaction appears to be most significant when ibuprofen is taken within 30 minutes after taking aspirin. The FDA states in the warning:
- Occasional use of ibuprofen is likely to cause minimal risk
- Spacing of ibuprofen at least 30 minutes after, or more than 8 hours before, aspirin ingestion is suggested
- This problem exists only with immediate-release aspirin.
Dr. Garrett is a clinical pharmacist practitioner at Cornerstone Health Care in High Point, NC.
Articles in this issue
almost 20 years ago
Equation for Success: Diabetes Medication, Diet, and Exercisealmost 20 years ago
Rx Product Newsalmost 20 years ago
OTC Product Newsalmost 20 years ago
can you READ these Rxs?almost 20 years ago
Juvenile Anabolic Steroid Abusealmost 20 years ago
Compounding Hotlinealmost 20 years ago
RESPy AWARD: A Role Model for Pharmacy Studentsalmost 20 years ago
Ouch! Time for Flu Shotsalmost 20 years ago
Supreme Court Declines to Review Generic Marketing PactsAdvertisement
Related to this article
Professional membership and experienced mentor leadership offer new pharmacy technicians a dual advantage, serving as a comprehensive training accelerator.
A biologic stewardship framework can enhance consistency, safety, and sustainability of biologic use in health systems.
Artificial intelligence (AI) transforms a chaotic, reactive process into an adaptive, proactive system that improves workflow and patient safety.
Pharmacists are well equipped to manage DOAC therapy by providing initial education, adherence support, and safety monitoring.
Pharmacists play a key role in guiding age- and risk-based vaccination decisions to protect against invasive and noninvasive disease.
Peer Reviewed
Gepotidacin and zoliflodacin show comparable efficacy to standard care for urogenital gonorrhea, offering promising alternatives given the recent rise in antimicrobial resistance.
With nearly 8 in 10 older adults misusing at least 1 OTC product, clearer counseling and labels could close the gap.
Advertisement
Advertisement
Trending on Pharmacy Times
1
New Bladder Cancer Regimens Reshape Treatment Across Disease Stages
2
FDA Approves Levacetylleucine to Treat Ataxia in Adult, Pediatric Patients With A-T
3
Biologic Stewardship: The Next Frontier for Health System Pharmacists
4
Adult Respiratory Vaccination Delivers Up to $12 in Societal Value for Every $1 Spent, Analysis Finds
5